Furosemide
- Product NDC
- 43353-221
- 11-digit product format
- 433530221
- Labeler code
- 43353
- Product ID
- 43353-221_0f3ae977-ba61-454c-902e-78c98d0884d4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Furosemide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA077293
- Marketing category
- ANDA
- Marketing start
- 2006-02-01
- Marketing end
- 0000-00-00
- Substance
- FUROSEMIDE
- Active strength
- 40 mg/1
- Pharmacologic classes
- Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 43353-221-30 | 2023-01-30 | C162847 | 48780-1 | f386c64a-25cd-0266-e053-dadaa90a7c1a | FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg |
| 43353-221-45 | 2023-01-30 | C162847 | 48780-1 | f386c64a-25cd-0266-e053-dadaa90a7c1a | FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg |
| 43353-221-53 | 2023-01-30 | C162847 | 48780-1 | f386c64a-25cd-0266-e053-dadaa90a7c1a | FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg |
| 43353-221-60 | 2023-01-30 | C162847 | 48780-1 | f386c64a-25cd-0266-e053-dadaa90a7c1a | FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg |
| 43353-221-80 | 2023-01-30 | C162847 | 48780-1 | f386c64a-25cd-0266-e053-dadaa90a7c1a | FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg |
| 43353-221-92 | 2023-01-30 | C162847 | 48780-1 | f386c64a-25cd-0266-e053-dadaa90a7c1a | FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg |
| 43353-221-94 | 2023-01-30 | C162847 | 48780-1 | f386c64a-25cd-0266-e053-dadaa90a7c1a | FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg |
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43353-221 | FUROSEMIDE (FUROSEMIDE) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 3 | Legacy NDC, 7 package rows | 20191221_d19c0b31-bb9f-4457-9fdd-2dcd27f8b9bb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43353-221-30 | 43353022130 | 30 TABLET in 1 BOTTLE (43353-221-30) | 30 tablet | 2016-08-25 | 0000-00-00 | No | No | Current |
| 43353-221-45 | 43353022145 | 45 TABLET in 1 BOTTLE (43353-221-45) | 45 tablet | 2016-08-25 | 0000-00-00 | No | No | Current |
| 43353-221-53 | 43353022153 | 60 TABLET in 1 BOTTLE (43353-221-53) | 60 tablet | 2016-08-25 | 0000-00-00 | No | No | Current |
| 43353-221-60 | 43353022160 | 90 TABLET in 1 BOTTLE (43353-221-60) | 90 tablet | 2016-08-25 | 0000-00-00 | No | No | Current |
| 43353-221-80 | 43353022180 | 180 TABLET in 1 BOTTLE (43353-221-80) | 180 tablet | 2016-08-25 | 0000-00-00 | No | No | Current |
| 43353-221-92 | 43353022192 | 270 TABLET in 1 BOTTLE (43353-221-92) | 270 tablet | 2016-12-02 | 0000-00-00 | No | No | Current |
| 43353-221-94 | 43353022194 | 360 TABLET in 1 BOTTLE (43353-221-94) | 360 tablet | 2016-12-12 | 0000-00-00 | No | No | Current |